<?xml version="1.0" encoding="UTF-8"?>

<AdverseEvent xmlns="http://hl7.org/fhir">
  <id value="mii-exa-onko-oxaliplatin-neuropathy"/>
  <language value="en"/>
  <text>
    <status value="generated"/><div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: AdverseEvent mii-exa-onko-oxaliplatin-neuropathy</b></p><a name="mii-exa-onko-oxaliplatin-neuropathy"> </a><a name="hcmii-exa-onko-oxaliplatin-neuropathy"> </a><p><b>actuality</b>: Adverse Event</p><p><b>event</b>: <span title="Codes:{https://www.meddra.org 10034620}">Oxaliplatin-induced peripheral neuropathy, grade 3 (CTCAE v5.0)</span></p><p><b>subject</b>: <a href="Patient-example-modification.html">Martin Beispiel  Male, DoB: 1958-11-03</a></p><p><b>date</b>: 2024-06-10</p><p><b>detected</b>: 2024-06-05</p><p><b>recordedDate</b>: 2024-06-10</p><p><b>seriousness</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/adverse-event-seriousness non-serious}">Non-serious</span></p><p><b>severity</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/adverse-event-severity severe}">Severe</span></p><blockquote><p><b>suspectEntity</b></p><p><b>instance</b>: <a href="MedicationStatement-mii-exa-onko-modification-oxaliplatin-phase1.html">MedicationStatement: status = stopped; statusReason = Adverse reaction (disorder); medication[x] = Oxaliplatin; effective[x] = 2024-03-15 --&gt; 2024-06-10; note = FOLFOX4 - Cycles 1-6 only. Discontinued due to severe peripheral neuropathy. Patient experienced numbness and tingling in hands and feet (grade 3 CTCAE), interfering with daily activities.</a></p><h3>Causalities</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Assessment</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess certain}">Certain</span></td></tr></table></blockquote></div>
  </text>
  <actuality value="actual"/>
  <event>
    <coding>
      <system value="https://www.meddra.org"/>
      <code value="10034620"/>
      <display value="Peripheral sensory neuropathy"/>
    </coding>
    <text value="Oxaliplatin-induced peripheral neuropathy, grade 3 (CTCAE v5.0)"/>
  </event>
  <subject>
    <reference value="Patient/example-modification"/>
  </subject>
  <date value="2024-06-10"/>
  <detected value="2024-06-05"/>
  <recordedDate value="2024-06-10"/>
  <seriousness>
    <coding>
      <system value="http://terminology.hl7.org/CodeSystem/adverse-event-seriousness"/>
      <code value="non-serious"/>
    </coding>
  </seriousness>
  <severity>
    <coding>
      <system value="http://terminology.hl7.org/CodeSystem/adverse-event-severity"/>
      <code value="severe"/>
      <display value="Severe"/>
    </coding>
  </severity>
  <suspectEntity>
    <instance>
      <reference value="MedicationStatement/mii-exa-onko-modification-oxaliplatin-phase1"/>
    </instance>
    <causality>
      <assessment>
        <coding>
          <system value="http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess"/>
          <code value="certain"/>
          <display value="Certain"/>
        </coding>
      </assessment>
    </causality>
  </suspectEntity>
</AdverseEvent>